Correlation Between Peripheral Blood Biomarkers and Efficacy of PD-1/PD-L1 Inhibitors Treatment on Lung Cancer
Objective To investigate the predictive and guiding significance of peripheral blood biomarkers on the therapeutic effects of PD-1/PD-L1 inhibitor treatment on lung cancer patients. Methods We collected the data of 200 lung cancer patients treated with PD-1/PD-L1 inhibitors treatment, including clin...
Saved in:
Main Authors: | KE Ping, JIANG Bo, HE Wenjie, TU Changling, NIE Jun, ZHU Ying, YIN Qing, SUN Ruizhu |
---|---|
Format: | article |
Language: | ZH |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a7202bbdc4e14e0baee2aadfa41fd34c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Prognostic Significance of PD1 and PDL1 Gene Expression in Lung Cancer: A Meta-Analysis
by: Chih-Hao Chang, et al.
Published: (2021) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
by: Seetharamu N, et al.
Published: (2017) -
Efficacy of PD‐1/PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China
by: Jiamin Sheng, et al.
Published: (2021) -
A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors
by: Nagasaka M, et al.
Published: (2019) -
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy
by: Wolfram Samlowski, et al.
Published: (2021)